Difass International and Expharma Limited: license agreement on Repenil®
Difass International and Expharma Limited negotiated a license agreement for Repenil®, a patented topical product indicated for the treatment of itching.
http://www.newswire.com/news/difass-international-negotiates-exclusive-licence-deal-with-expharma-19649237
http://www.newswire.com/news/difass-international-negotiates-exclusive-licence-deal-with-expharma-19649237
Researching for health, every day together
Registered Office and Headquarters
Via Ausa, 5
47853 Coriano (Rn)
Legality rating:
VAT registration number P.Iva 02172260974
Business register of Rimini
REA number 315285
Corporation stock in euro 700.000 €
Are you a physician or a private customer? Contact us at info@difass.com
Are you a company? Contact us at bd@difass.com
Associato a:
Credits TITANKA! Spa